BPMC – blueprint medicines corporation (US:NASDAQ)
Stock Stats
News
Blueprint Medicines Co. (NASDAQ: BPMC) had its price target raised by analysts at Citigroup Inc. from $65.00 to $76.00. They now have a "sell" rating on the stock.
Blueprint Medicines Co. (NASDAQ: BPMC) had its price target raised by analysts at JMP Securities from $114.00 to $125.00. They now have a "market outperform" rating on the stock.
Blueprint Medicines Co. (NASDAQ: BPMC) had its price target raised by analysts at HC Wainwright from $125.00 to $135.00. They now have a "buy" rating on the stock.
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises [Yahoo! Finance]
Blueprint Medicines Co. (NASDAQ: BPMC) had its price target raised by analysts at Barclays PLC from $70.00 to $75.00. They now have an "equal weight" rating on the stock.
Form 10-Q Blueprint Medicines Corp For: Mar 31
Form 144 Blueprint Medicines Corp Filed by: Landsittel Michael
Form 144 Blueprint Medicines Corp Filed by: Hurley Ariel
Form 8-K Blueprint Medicines Corp For: May 02
Form ARS Blueprint Medicines Corp For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.